INTRODUCTION
Sulphation is one of the major conjugation reactions involved with the biotransformation of a wide variety of drugs, xenobiotics and endogenous compounds bearing a hydroxy or nitrogen functional group (Mulder, 1981) . Conjugation of these compounds with sulphate is catalysed by a family of enzymes termed sulphotransferases (STs). One of the major roles of the STs in drug metabolism is the conversion of a substance into a more soluble, and therefore more readily excretable, form via formation of a sulphate or sulphamate conjugate. 3'-Phosphoadenosine 5'-phosphosulphate (PAPS) serves as the donor of the sulphate moiety for all mammalian STs (Huxtable, 1986) . In addition to its role in increasing excretion, conjugation with sulphate can also serve to convert compounds into their biologically active forms (Huxtable, 1986) or into reactive toxic electrophiles (Miller & Miller, 1969; Hanna & Banks, 1985; Huxtable, 1986) .
Minoxidil (Mx), a pyrimidine N-oxide, is an important therapeutic vasodilating agent for which ST activity has been implicated in conversion of the drug into its biologically active form.
The efficacy of Mx as a vasodilating agent has been demonstrated to be dependent upon sulphation at the N-oxide position (McCall et al., 1983) . Subsequently Waldon et al. (1989) reported that the NO-sulphate of Mx is also responsible for inducing hair growth in cultured hair follicles. These results suggest that the increase in hair growth observed with patients using topical Mx is a consequence of the synthesis of Mx NO-sulphate and its action on hair follicles. Sulphation therefore apparently plays a vital role in the varied pharmacological activities of Mx. Johnson et al. (1982) have reported the presence of Mx-ST activity in the cytosolic fraction of male rat liver. This enzyme activity serves to convert Mx only into the NO-sulphate metabolite (McCall et al., 1983) . Rat liver cytosol was also shown to possess enzyme activities capable of sulphating several other different pyrimidine, pyridine, triazine and imidazole N-oxides (McCall et al., 1983) . However, identification of specific forms of ST capable of catalysing the sulphation of the N-oxide moiety of these compounds has not been reported.
A number ofdifferent forms ofST activity capable ofcatalysing the sulphation of small phenols Borchardt & Schasteen, 1982) , steroids (Lyon et al., 1981) , bile acids (Chen et al., 1977; Barnes et al., 1989) and N-hydroxyarylamines (Wu & Straub, 1976; Sekura & Jakoby, 1981) have been identified and isolated from rat liver cytosol. However, only two of these ST activities have been reported to form NO-sulphate esters. Wu & Straub (1976) purified an ST activity from male rat liver cytosol that catalyses the sulphation ofp-nitrophenol (PNP) and of N-hydroxy-2-acetamidofluorene (N-OH-2AAF) to the highly reactive product N-sulpho-oxy-AAF. Subsequently identified four forms of aryl-ST (AST) activity, AST I, AST II, AST III and AST IV, in male rat liver cytosol. Each of the forms of AST was active with a wide variety of phenolic compounds, such as ,-naphthol and PNP; however, only AST IV was capable of sulphating organic hydroxylamines, including N-OH-2AAF (Sekura & Jakoby, 1981) . It is not known if either N-OH-2AAF-ST or AST IV is capable of conjugating the Noxide moiety of Mx. The present paper describes the purification and characterization of Mx-ST from male rat liver cytosol. Mx-ST is the major ST in rat liver cytosol responsible for the sulphation of Mx, and the purified enzyme was also capable of sulphating small phenols such as PNP. During the purification process Mx-ST was also resolved from several other ST activities that were active in sulphating PNP but were not capable of conjugating Mx. The data in this paper indicate that Mx-ST represents a unique form Vol. 270 Abbreviations used: Mx, minoxidil; PNP, p-nitrophenol; N-OH-2AAF, N-hydroxy-2-acetamidofluorene; PAPS, 3'-phosphoadenosine 5'-phosphosulphate; Mx-ST, minoxidil sulphotransferase; PNP-ST, p-nitrophenol sulphotransferase; N-OH-2AAF-ST, N-hydroxy-2-acetamidofluorene sulphotransferase; AST, arylsulphotransferase; M-PST and P-PST, monoamine-sulphating and phenol-sulphating forms of phenol sulphotransferase respectively; DHEA-ST, dehydroepiandrosterone sulphotransferase; BAST, bile acid sulphotransferase. Isoelectric-focusing gels were purchased from FMC Bioproducts (Rockland, ME, U.S.A.). All other chemicals were of reagentgrade quality.
Purification procedure
Livers were obtained from male or female Sprague-Dawley rats (175-200 g; Charles Rivers Breeders, Portage, MI, U.S.A.) and were stored at -70°C before use. Cytosol was prepared from other male rat tissues as described for preparation of liver cytosol. The purification procedure beyond cytosol preparation was conducted with livers from only male rats, and unless otherwise noted all purification steps were carried out at 4 'C.
Step 1. Preparation of rat liver cytosol. Frozen rat livers were thawed in 3 vol. of buffer A [10 mM-Tris/HCI buffer, pH 7.4, containing 0.25 M-sucrose, I mM-dithiothreitol and 10 % (v/v) glycerol] and homogenized twice for 30 s in a Brinkman Polytron homogenizer. The homogenate was then centrifuged at 12000 g for 10 min, and the resulting supernatant fluid was centrifuged at 100000 g for 60 min. The low-density material at the top of each tube was removed by filtering the supernatant fluid through several layers of cheesecloth. The filtered liver cytosol preparations were stored at -70 'C and used within 6 weeks. Protein determinations were carried out by using the Bio-Rad protein assay originally described by Bradford (1976) , with BSA as a standard.
Step 2. DEAE-Sepharose chromatography. Rat liver cytosol was thawed on ice, centrifuged at 10000 g to remove any precipitated protein and applied to a DEAE-Sepharose CL-6B column (2.5 cm x 10 cm) that had been previously equilibrated in buffer A. The anion-exchange column was then washed with 50 ml of buffer A, followed by 130 ml of buffer A containing 50 mM-NaCl. Next, Mx-ST activity was eluted with a linear gradient established between 300 ml of buffer A containing 50 mM-NaCl and 300 ml of buffer A containing 200 mM-NaCl. Fractions (7.5 ml) were collected, and Mx-ST Step 3. Hydroxyapatite chromatography. After dialysis, Mx-ST activity was applied to a hydroxyapatite column (2.5 cm x 3 cm) that had been previously equilibrated in buffer B without glycerol.
The column was washed with 20 ml of the same buffer, and Mx-ST activity was eluted with a linear gradient established between 150 ml of buffer B without glycerol and 150 ml of 150 mmpotassium phosphate buffer, pH 6.8, both containing 0.25 Msucrose and I mM-dithiothreitol. Fractions (3.75 ml) were collected and Mx-ST and PNP-ST ac'tivities were determined.
Step 4. ATP-agarose affinity chromatography. Fractions from the hydroxyapatite column containing Mx-ST activity were combined and concentrated approximately 8-fold by ultrafiltration on an Amicon PM-30 membrane. Mx-ST activity was then applied at 25°C to an ATP-agarose column (1.3 cm x 3.5 cm) that had been previously equilibrated in buffer C [10 mmsodium phosphate buffer, pH 6.8, containing 0.25 M-sucrose, 1 mM-dithiothreitol and 10 % (v/v) glycerol]. The affinity column was washed with 25 ml of buffer C. Mx-ST activity was then specifically eluted with a linear gradient established between 10 ml of buffer C and 10 ml of buffer C containing 10 1uM-PAPS. Fractions (approx. 1.3 ml) were collected and assayed for Mx-ST and PNP-ST activities.
Enzyme assays
Mx-ST activity was assayed by using the extraction procedure for Mx NO-sulphate described by Johnson & Baker (1987) . The Mx-ST reaction mixture contained 240 mM-Hepes/NaOH buffer, pH 7.3, 1 mM-Mx and 7 mM-dithiothreitol. Reactions were started by the addition of [35S]PAPS to a final concentration of 29 fM and the mixture was incubated for 10 min at 37 'C. The optimum pH for Mx-ST activity was 7.3 in Hepes buffer. Reactions were terminated by the addition of 1 ml of ethyl acetate to the reaction mixture, which was immediately placed on ice, and this was followed by 0.4 ml of 1 M-NH3 to alkalinize the solution. The reaction mixture was vortex-mixed for 15 s, then centrifuged at 800 g to separate the organic and aqueous phases, and the radioactivity in 0.5 ml of the ethyl acetate phase was quantified by scintillation spectrometry. This extraction takes advantage of the unusual hydrophobicity of Mx NO-sulphate, which is more soluble in organic solvents than in water (McCall et al., 1983) .
PNP-ST activity was assayed by using the barium precipitation method of Foldes & Meek (1973) . The optimum pH for PNP sulphation catalysed by Mx-ST was 6.5-6.8 in triethanolamine buffer. The reaction mixture contained 50 mM-triethanolamine/ HCI buffer, pH 6.8, 1.2 1M-PNP and enzyme. Reactions were initiated by the addition of [35S]PAPS to a final concentration of 20^M , in a final reaction volume of 0.25 ml. Reactions were terminated by the addition of 50,1 each of 0.1 M solutions of barium acetate, Ba(OH)2 and ZnSO4. The resulting precipitate was removed by centrifugation at 1500 g for 5 min, and the supernatant was transferred to new microcentrifuge tubes, whereupon the reaction mixture was reprecipitated with barium acetate, Ba(OH)2 and ZnSO4. The resulting precipitate was then removed by centrifugation at 12000 g for 3 min and the radioactivity in 250 ,u1 of the supernatant fluid was determined by scintillation spectrometry. ST assays with both Mx and PNP were linear with respect to time and protein concentration.
SDS/PAGE
SDS/PAGE was performed in the presence of SDS with the use of a Bio-Rad Protean II unit and the buffer system described by Laemmli (1970) . Samples were pretreated with the addition of 2-mercaptoethanol and SDS to final concentrations of 5 % (v/v) and 1% (w/v) respectively, and then heated at 100 'C for 10 min. After electrophoresis, the gels were stained with Coomassie Blue R-250 as previously described by Falany & Tephly (1983) . Minimum subunit molecular masses were estimated by comparison with commercial molecular-mass standards (Sigma Chemical Co.).
Sephacryl S-200 chromatography Gel exclusion chromatography was used to estimate the molecular mass of the active form of Mx-ST. Concentrated Mx-ST activity obtained after the hydroxyapatite chromatography procedure was applied to a Sephacryl S-200 gel-filtratiosi column (2.5 cm x 48 cm) that had been previously equilibrated in buffer A. Mx-ST was then eluted from the column with buffer A, and 1.5 ml fractions were collected. The elution of Mx-ST was compared with the elution of commercial molecular-mass standards (Sigma Chemical Co.).
Immunization protocol
Polyclonal antibodies were raised against purified Mx-ST in a female New Zealand White rabbit. The initial challenge consisted of 50 ,ug of pure Mx-ST in complete Freund's adjuvant injected into eight subcutaneous sites along the shaved back of the animal. The rabbit was boosted 2 weeks later with another 50 jig of Mx-ST in incomplete Freund's adjuvant. The rabbit was then injected with 30,g of Mx-ST 6 weeks later, followed by an additional 30,ug of protein 4 weeks later. The rabbit was bled 2 weeks after each injection and the sera were tested for immunoreactivity by using an immunoblotting protocol.
Immunoblot procedure
Proteins were resolved by SDS/PAGE in a 12.5 % polyacrylamide gel and electrophoretically transferred to nitrocellulose paper by means of a Bio-Rad Transblot apparatus and the buffer system described by Towbin et al. (1979) . Gelatin (3 %, w/v) in Tris-buffered saline (500 mM-NaCI/20 mM-Tris/ HCI buffer, pH 7.5) was used for blocking of the nitrocellulose, and incubations in primary antibody were carried out overnight at 28°C with gentle shaking in Tris-buffered saline containing 0.1 % Tween-20 and 1% gelatin. A 1:5000 dilution of rabbit anti-(rat Mx-ST) IgG fraction (0.5 ,Cg of protein/,ul before dilution) was normally used as primary antibody. The IgG fraction of the antiserum was prepared by Protein A-Sepharose 4B chromatography by the method of Harlow & Lane (1988 tivities in rat liver cytosol Male rat liver cytosol (1200 mg) was applied to a DEAE-Sepharose CL-6B column (2.5 cm x 10 cm) that had been equilibrated in buffer A. The column was then washed with 50 ml of buffer A, followed by 150 ml of buffer A containing 50 mM-NaCl. Mx-ST activity was subsequently eluted with a linear gradient (--) consisting of 300 ml of buffer A and 300 ml of buffer A containing 200 mMNaCl. Fractions (7.5 ml) were collected and Mx-ST activity (-) and PNP-ST activity (0) were determined using assay concentrations of t Represents 0.06 % recovery of PNP-ST total activity after the final step in the purification procedure. CL-6B procedure were concentrated by ultrafiltration, dialysed and applied to a hydroxyapatite column (2.5 cm x 3 cm) that had been equilibrated in buffer B without glycerol. The column was then washed with 20 ml of the same buffer, and the ST activities were eluted with a linear gradient (300 ml total volume; --) between this buffer and 150 mM-potassium phosphate buffer, pH 6.8, containing 0.25 M-sucrose and 1 mM-dithiothreitol. Fractions (approx. 3.8 ml) were collected and Mx-ST (M) and PNP-ST (0) activities were assayed as described for Fig. 1. 115 mM-NaCl. PNP-sulphation activity was eluted during the anion-exchange procedure as two major peaks at about 75 mMNaCl and 105 mM-NaCl and a minor peak at 55 mM-NaCl.
Fractions containing high levels of Mx-ST activity and relatively low levels of PNP-ST activity were combined. With respect to the two enzyme activities in rat liver cytosol, the DEAE-Sepharose chromatography procedure gave a 7.7-fold purification of Mx-ST activity in comparison with only a 1.2-fold purification of PNP-ST activity (Table 2) . Fig. 2 shows the elution of Mx-ST activity during hydroxyapatite chromatography. All of the Mx-ST activity applied to the hydroxyapatite column was adsorbed on the resin and it was eluted with approx. 115 mM-potassium phosphate buffer. Fig. 2 also illustrates that hydroxyapatite chromatography was effective in resolving other PNP-ST activities from the Mx-ST activity; however, some PNP-ST activity was still co-eluted with Mx-ST activity. Although the procedure resulted in a decrease in the purification of Mx-ST and PNP-ST activities as compared with cytosol (Table 2) , hydroxyapatite chromatography was essential for obtaining pure Mx-ST. Mx-ST was subsequently purified to homogeneity by using ATP-agarose affinity chromatography (Fig. 3) . Most of the applied Mx-ST activity was retained on the affinity column and was specifically eluted as a sharp peak of activity at approx. 5 ,uM-PAPS during a 0-10 /tM-PAPS gradient. Fig. 3 also shows that some PNP-ST activity was co-eluted with Mx-ST activity during the affinity-chromatography procedure. The results of a typical purification procedure are presented in Table 2 . After the affinity-chromatography procedure, Mx-ST activity and its associated PNP-sulphation activity were purified 237-fold and 28-fold respectively, and with a recovery of 4.8 % of the initial Mx-ST activity. Also, more Mx-ST activity was obtained after the affinity-chromatography procedure than was obtained after hydroxyapatite chromatography. These results suggest that Mx-ST activity was inhibited under the conditions used to perform the hydroxyapatite chromatography, and this inhibition may be the reason for the decrease in purification observed after this procedure (Table 2) .
Although purified Mx-ST was capable of sulphating PNP, the ATP-agarose chromatography procedure was also capable of resolving another form of PNP-ST activity from Mx-ST. This is shown by the increase achieved in the ratio of the specific activity of Mx-ST to that of PNP-ST activity after affinity chromatography (Table 2) . Furthermore, when PNP-ST activity was (0) and ATP-agarose (a) chromatography procedures that contained high levels of Mx-ST activity. assayed in fractions from the hydroxyapatite column that contained Mx-ST activity, a biphasic pattern of activity was observed with increasing PNP concentrations (Fig. 4) (Wu & Straub, 1976; from male rat liver (mRLC), female rat liver (fRLC), kidney, small intestine lung and brain were resolved by SDS/PAGE in a 12.5 % polyacrylamide gel and electrophoretically transferred to nitrocellulose with the use of the buffer system described by Towbin et al. (1979) . A 1:5000 dilution of rabbit anti-Mx-ST IgG was used as primary antibody and the immunoconjugates were detected with goat anti-(rabbit IgG) antibody-alkaline phosphatase conjugate second antibody as described in the Experimental section.
Vol. 270 were resolved by SDS/PAGE in a 12.5 % polyacrylamide gel and electrophoretically transferred to a nitrocellulose filter. Immunoreactive proteins were detected with a 1: 10000 dilution of rabbit anti-(human PST) serum and the immunoconjugates were detected with goat anti-(rabbit IgG) antibody-alkaline phosphatase conjugate second antibody as described in the Experimental section.
reactive protein with the same molecular mass as Mx-ST in both cytosolic preparations (Fig. 6) . The relative level of immunoreactivity was greater in male cytosol than in female cytosol, and this result was consistent with the observation that male rat liver possessed about 2-fold greater Mx-ST activity than female liver (Table 1 ). In comparison with liver, Fig. 6 also shows no detectable immunoreactivity in cytosolic preparations of several male rat tissues that did not possess detectable Mx-ST activity. Our laboratory has previously reported the characterization of an antibody raised against the monoamine-sulphating form of human platelet phenol ST, M-PST (Heroux et al., 1989) . This antibody reacts with both the monoamine (M)-and phenol (P)-sulphating forms of PST, but not with DHEA-ST, a steroid ST purified from human liver . To investigate the immunological relationship between rat Mx-ST and human liver STs, Mx-ST was tested for cross-reactivity with the rabbit anti-(human PST) antibody. Fig. 7 shows that affinity-purified Mx-ST was recognized by the anti-(human PST) antibody during an immunoblotting procedure. However, several other proteins in male rat liver cytosol were also reactive with the anti-(human PST) serum. The identities of the other cross-reactive proteins in rat liver cytosol are not known but may represent other forms of ST. Conversely, a 1: 5000 dilution of rabbit anti-(rat Mx-ST) IgG was also capable of reacting with the purified human liver P-PST. However, the rabbit anti-Mx-ST antibody also recognized purified human DHEA-ST during the immunoblotting procedure (result not shown).
Kinetics
Substrate inhibition of Mx-ST activity was observed when reaction concentrations above 1.2 ,tM-PNP (Fig. 4) approx. 55 % by the presence of 0.5 ,tM-PNP. These results are consistent with the apparent sulphation of PNP by Mx-ST. However, the exact mechanism by which PNP inhibits Mx-ST activity was not determined because of the substrate inhibition observed with both PNP and Mx.
Amino acid composition
The amino acid composition of Mx-ST was determined for comparison with the reported compositions of other rat liver STs. Table 3 shows the number of residues estimated for each amino acid present in Mx-ST in comparison with the reported amino acid compositions of several other rat STs. The composition of Mx-ST appears to be most similar to that reported for AST IV; however, significant differences are observed in the numbers of methionine, threonine and leucine residues between these enzymes. The composition of Mx-ST differs the most from that for the rat liver bile acid ST (BAST), the one ST that does not sulphate small phenolic compounds.
Discussion
This paper describes the purification and characterization of Mx-ST from male rat liver cytosol. The enzyme preparation was homogeneous as evaluated by SDS/PAGE, isoelectric focusing and h.p.l.c. analysis. An overall purification of approx. 240-fold was achieved and the pure enzyme had a specific activity of approx. 120 nmol of Mx and 41 nmol of PNP sulphated/min per mg of protein. Mx-ST therefore represents approx. 0.4 % of rat cytosolic protein and the PNP-ST activity of the pure enzyme represents about 11 % of the cytosolic PNP-ST activity. The fold purification obtained for purified Mx-ST is slightly lower than the purifications (280-610-fold) reported for other male rat liver STs Borchardt & Schasteen, 1982) , and the specific activity of purified Mx-ST for PNP sulphation was lower than that reported for AST I, AST II and AST IV, but higher than for the PST purified by Borchardt & Schasteen (1982) .
In rat liver Mx-ST appears to be related to a family of STs that are capable of sulphating small phenols such as PNP. Several rat STs that have been reported to catalyse PNP sulphation have been purified and characterized. These include AST I, AST II, AST III and AST IV , N-OH-2AAF-ST (Wu & Straub, 1976 ) and a different rat liver PST isolated by Borchardt & Schasteen (1982 (Wu & Straub, 1976; Sekura & Jakoby, 1979 Borchardt & Schasteen, 1982) . Also, the PNP concentration for maximal activity with Mx-ST is less than the Km values for PNP sulphation reported for previously purified rat STs (Sekura & Jakoby, 1979 Borchardet at., 1982 (Meisheri & Cipkus, 1987) , possess Mx-ST activity or respond to circulating concentrations of Mx NO-sulphate. Also, it is not known if Mx-ST has a physiological role in the activation via sulphation of endogenous compounds similar to Mx.
Mx is sulphated in human liver by the phenol-sulphating form of phenol ST, P-PST (Falany & Kerl, 1990) . Rat liver Mx-ST is similar to P-PST in that both enzymes sulphate PNP in the micromolar range, as well as Mx. P-PST and Mx-ST also share immunological similarity, since anti-Mx-ST antibodies recognize P-PST and rabbit anti-(human P-PST) antibodies recognize Mx-ST. These similarities suggest that sulphation of Mx in rats may provide a model system for Mx sulphation in humans. However, in contrast with rats, P-PST is present in many different human tissues, including liver , platelets (Hart et al., 1979; Anderson et al., 1981) , intestine (Bostrum & Wengle, 1967; Wong, 1976 ) and brain (Rein et al., 1984) . Furthermore, the ability to sulphate an N-oxide suggests the possibility that Mx-ST may be capable of sulphating other Nhydroxy compounds or carcinogenic substrates such as 1'-hydroxysafrole and N-OH-2AAF. Studies on the further characterization and localization of Mx-ST will aid in our understanding of the role of sulphation in the pharmacology of N-oxide compounds.
